These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8643355)

  • 1. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing.
    Puttaraju M; Been MD
    Nucleic Acids Symp Ser; 1995; (33):49-51. PubMed ID: 8643395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV gene regulatory proteins tat and rev and their interactions with synthetic RNA.
    Asseline U; Grasby J; Hamy F; Iwai S; Mann DA; Pritchard C; Karn J; Gait MJ
    Nucleic Acids Symp Ser; 1993; (29):113-4. PubMed ID: 7504239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RNA ligands for HIV proteins].
    Iwai S
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
    Peterson RD; Feigon J
    J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circularizing ribozymes and decoy-competitors by autocatalytic splicing in vitro and in vivo.
    Puttaraju M; Been MD
    SAAS Bull Biochem Biotechnol; 1996; 9():77-82. PubMed ID: 8652136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA binding by the tat and rev proteins of HIV-1.
    Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
    Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro selection of RNA aptamers that can bind specifically to Tat protein of HIV-1.
    Yamamoto R; Toyoda S; Viljanen P; Machida K; Nishikawa S; Murakami K; Taira K; Kumar PK
    Nucleic Acids Symp Ser; 1995; (34):145-6. PubMed ID: 8841594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of a non-nucleotide bridge into hairpin oligonucleotides capable of high-affinity binding to the Rev protein of HIV-1.
    Nelson JS; Giver L; Ellington AD; Letsinger RL
    Biochemistry; 1996 Apr; 35(16):5339-44. PubMed ID: 8611522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide models of the Tat-TAR protein-RNA interaction.
    Frankel AD
    Protein Sci; 1992 Dec; 1(12):1539-42. PubMed ID: 1304886
    [No Abstract]   [Full Text] [Related]  

  • 19. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
    Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
    J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.